{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:07:13Z","timestamp":1789880833890,"version":"4.0.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T00:00:00Z","timestamp":1242172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1756-8722-2-20","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T19:30:23Z","timestamp":1242243023000},"source":"Crossref","is-referenced-by-count":56,"title":["Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra\u00ae, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome"],"prefix":"10.1186","volume":"2","author":[{"given":"Azra","family":"Raza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Galili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Callander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonel","family":"Ochoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Piro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Emanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Howard","family":"Burris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Faderl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeev","family":"Estrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Curtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G","family":"Keck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail L","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,13]]},"reference":[{"key":"47_CR1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0889-8588(18)30324-1","volume":"6","author":"PA Kouides","year":"1992","unstructured":"Kouides PA, Bennett JM: Morphology and classification of myelodysplastic syndromes. Hematol Oncol Clin North Am. 1992, 6: 485-499.","journal-title":"Hematol Oncol Clin North Am"},{"key":"47_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2141.1983.tb02852.x","volume":"55","author":"DJ Weisdorf","year":"1983","unstructured":"Weisdorf DJ, Oken MM, Johnson GJ, Rydell RE: Chronic myelodysplastic syndrome: Short survival with or without evolution to acute leukaemia. Br J Haematol. 1983, 55: 691-700. 10.1111\/j.1365-2141.1983.tb02852.x.","journal-title":"Br J Haematol"},{"key":"47_CR3","first-page":"953","volume-title":"Clinics in Haematology","author":"GJ Mufti","year":"1986","unstructured":"Mufti GJ, Galton DAG: Myelodysplastic Syndromes: Natural History and Features of Prognostic Importance. Clinics in Haematology. Edited by: Griffin JD. 1986, London, UK: W.B. Saunders Company, 953-971."},{"key":"47_CR4","first-page":"909","volume-title":"Clinics in Haematology","author":"JM Bennett","year":"1986","unstructured":"Bennett JM: Classification of the Myelodysplastic Syndromes. Clinics in Haematology. Edited by: Griffin JD. 1986, London, UK: W. B. Saunders Company, 909-923."},{"key":"47_CR5","first-page":"134b","volume-title":"Proceedings of the Annual Meeting of the American Society of Hematology; December 6\u201310","author":"AS Morgan","year":"1996","unstructured":"Morgan AS, Stanboli A, Sanderson PE: TER199 Increases Bone Marrow (BM) CFU-GM and Peripheral Platelet and Neutrophil Counts in Myelosuppressed Rodents. Proceedings of the Annual Meeting of the American Society of Hematology; December 6\u201310. 1996, 134b- ; Orlando, Florida. Abstract #3263"},{"key":"47_CR6","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/emboj\/18.5.1321","volume":"18","author":"V Adler","year":"1999","unstructured":"Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD: Regulation of JNK signaling by GSTp. EMBO J. 1999, 18: 1321-1334. 10.1093\/emboj\/18.5.1321.","journal-title":"EMBO J"},{"key":"47_CR7","first-page":"214","volume-title":"Proceedings of the American Association for Cancer Research; March 24\u201328","author":"F Meng","year":"2001","unstructured":"Meng F, Broxmeyer HE, Toavs D, Cristobal C, Morgan A, Gomez R: TLK199: A Novel, Small Molecule Myelostimulant. Proceedings of the American Association for Cancer Research; March 24\u201328. 2001, 214- ; New Orleans, Louisiana. Abstract #1144"},{"key":"47_CR8","first-page":"652a","volume-title":"Proceedings of the Annual Meeting of the American Society of Hematology; December 4\u20137","author":"PD Emanuel","year":"2004","unstructured":"Emanuel PD, Wang Z, Cai D, Stofega MR, Keck JG, Estrov Z: TLK199 (Telintra\u2122), a Novel Glutathione Analog Inhibitor of GST P1-1, Causes Proliferation and Maturation of Bone Marrow Precursor Cells and Correlates with Clinical Improvement in Myelodysplastic Syndrome (MDS) Patients in a Phase 2a Study. Proceedings of the Annual Meeting of the American Society of Hematology; December 4\u20137. 2004, 652a- ; San Diego, California. Abstract #2372"},{"key":"47_CR9","volume-title":"DCTD, NCI, NIH, DHHS","author":"NCI Common Toxicity Criteria. Common Toxicity Criteria (CTC)","year":"1998","unstructured":"NCI Common Toxicity Criteria. Common Toxicity Criteria (CTC): 1\u201335. 4-30-1999. CTEP. Cancer Therapy Evaluation Program, Common Terminology Criteria Version 2.0. DCTD, NCI, NIH, DHHS. 1998"},{"key":"47_CR10","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1073\/pnas.95.9.5275","volume":"95","author":"CJ Henderson","year":"1998","unstructured":"Henderson CJ, Smith AG, Ure J, Brown K, Bacon EJ, Wolf CR: Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc Natl Acad Sci USA. 1998, 95: 5275-5280. 10.1073\/pnas.95.9.5275.","journal-title":"Proc Natl Acad Sci USA"},{"key":"47_CR11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-3565(24)29386-1","volume":"298","author":"JE Ruscoe","year":"2001","unstructured":"Ruscoe JE, Rosario LA, Wang T, Gate L, Arifoglu P, Wolf CR: Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTp) influences cell proliferation pathways. J Pharmacol Exp Ther. 2001, 298: 339-345.","journal-title":"J Pharmacol Exp Ther"},{"key":"47_CR12","first-page":"3671","volume":"96","author":"BD Cheson","year":"2000","unstructured":"Cheson BD, Bennett JM, Kantarjian H, Pinto A, Schiffer CA, Nimer SD: Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood. 2000, 96: 3671-3674.","journal-title":"Blood"},{"key":"47_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1182\/blood-2005-10-4149","volume":"108","author":"BD Cheson","year":"2006","unstructured":"Cheson BD, Greenberg PL, Bennett JM, Lowenberg B, Wijermans PW, Nimer SD: Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood. 2006, 108: 419-425. 10.1182\/blood-2005-10-4149.","journal-title":"Blood"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-8722-2-20.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-8722-2-20\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-8722-2-20.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T11:38:51Z","timestamp":1739101131000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/1756-8722-2-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,13]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["47"],"URL":"https:\/\/doi.org\/10.1186\/1756-8722-2-20","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,13]]},"article-number":"20"}}